Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
mBio ; 15(1): e0146423, 2024 Jan 16.
Article in English | MEDLINE | ID: mdl-38117035

ABSTRACT

IMPORTANCE: Our study reveals the potential of precision-cut lung slices as an ex vivo platform to study the growth/survival of Pneumocystis spp. that can facilitate the development of new anti-fungal drugs.


Subject(s)
Anti-Infective Agents , Pneumocystis , Pneumonia, Pneumocystis , Lung/microbiology , Pneumonia, Pneumocystis/microbiology
2.
Methods Mol Biol ; 2667: 169-179, 2023.
Article in English | MEDLINE | ID: mdl-37145284

ABSTRACT

Pneumocystis jirovecii causes pneumonia in immunocompromised patients. A major challenge in drug susceptibility testing and in understanding host/pathogen interactions is that Pneumocystis spp. are not viable in vitro. Continuous culture of the organism is not currently available, and therefore, developing new drug targets is very limited. Due to this limitation, mouse models of Pneumocystis pneumonia have proven to be an invaluable resource to researchers. In this chapter, we provide an overview of selected methods used in mouse models of infection including, in vivo Pneumocystis murina propagation, routes of transmission, genetic mouse models available, a P. murina life form-specific model, a mouse model of PCP immune reconstitution inflammatory syndrome (IRIS), and the experimental parameters associated with these models.


Subject(s)
Mycobacterium tuberculosis , Pneumocystis carinii , Pneumonia, Pneumocystis , Animals , Mice , Microbial Sensitivity Tests , Pneumocystis carinii/genetics , Pneumonia, Pneumocystis/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...